TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2016

Phase III Trial Evaluating Letrozole As First-Line Endocrine Therapy With or Without Bevacizumab for the Treatment of Postmenopausal Women With Hormone Receptor-Positive Advanced-Stage Breast Cancer: CALGB 40503 (Alliance).

Maura N Dickler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.